The U.S. Food and Drug Administration approved Mirum Pharmaceuticals' genetic disorder drug on Friday, making it the first ...
For some patients born with a certain skull abnormality, unexpectedly early cognitive decline and symptoms of depression and anxiety may be corrected with a brain surgery, report University of ...
The following is a summary of “Efficacy of acetylcholinesterase inhibitors on reducing hippocampal atrophy rate: a systematic review and meta-analysis,” published in the February 2025 issue of BMC ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results